Quality of life assessment among HIV-positive persons entering the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

摘要

ObjectivesWith HIV treatment prolonging survival and HIV infection now managed as a chronic illness, quality of life (QOL) is important to evaluate in persons living with HIV (PLWH). We assessed at study entry the QOL of antiretroviral-naive PLWH with CD4 counts >500 cells/L in the Strategic Timing of AntiRetroviral Treatment (START) clinical trial.